Skip to main content

ADVERTISEMENT

imatinib mesylate

Research in Review
02/22/2017
JCP Editors
Imatinib mesylate front-line treatment of advanced or metastatic gastrointestinal stromal tumors (GISTs) leads to significant long-term survival in patients with a specific genetic mutation, according to study...
Imatinib mesylate front-line treatment of advanced or metastatic gastrointestinal stromal tumors (GISTs) leads to significant long-term survival in patients with a specific genetic mutation, according to study...
...
02/22/2017
Journal of Clinical Pathways